Navigation Links
UC Davis researchers discover new drug target for inflammatory disease
Date:9/22/2008

(SACRAMENTO, Calif.) UC Davis researchers have defined a cellular process that promotes inflammation and, at the same time, found an important starting point for identifying and testing new drugs for diseases such as sepsis, rheumatoid arthritis, cardiovascular disease and some cancers.

The scientists discovered that a protein called sPLA2-IIA binds to two integrins labeled alpha-V-beta-3 and alpha-4-beta-1, causing them to rapidly multiply and boosting an immune system response already gone awry due to disease.

"We have known for a while that this protein is elevated with inflammation," said Yoshikazu Takada, UC Davis professor of dermatology and lead author of the study, which appears in the September 19 issue of The Journal of Biological Chemistry. "Our outcome shows with much more precision how the protein actually works to advance inflammation. The potential impact of the finding on our ability to block inflammation and stop the disease process in its tracks is enormous."

Protein sPLA2-IIA has been a major drug discovery target for years, but efforts to counteract the protein have yielded mixed results. Takada explains that this is due to the fact that its intercellular relationships in humans were not well-known. Scientists have previously identified receptors for the protein in mice cells. However, Takada and his team are the first to find that the protein binds to completely different receptors the two integrins in human cells.

Integrins are the "networkers" of the immune system, playing key roles in the attachment of cells to other cells. Integrins are also important to signal transduction, the process by which a cell transforms from one kind of signal or stimulus into another.

"We need to know the mechanisms of inflammation to be able to disrupt it," said Takada. "Now that we know more about how this protein interacts with these integrins, researchers can be much more successful in screening
'/>"/>

Contact: Karen Finney
karen.finney@ucdmc.ucdavis.edu
916-734-9064
University of California - Davis - Health System
Source:Eurekalert

Page: 1 2

Related biology news :

1. UC Davis researchers define characteristics, treatment options for XXYY syndrome
2. UC Davis researcher leads climate-change discovery
3. UC Davis stem researchers demonstrate safety of gene therapy using adult stem cells
4. UC Davis researchers discover how HIV turns food-poisoning into lethal infection
5. UC Davis bird-flu expert calls for changes in early-warning system
6. Pittsburgh researchers identify source of multipotent stem cells with broad regenerative potential
7. U of M researchers identify gene linked to common ailment in labrador retrievers
8. Friendly bacteria protect against type 1 diabetes, Yale researchers find
9. Using novel tool, UD researchers dig through cell trash and find treasure
10. More than skin deep: Theres no such thing as a safe suntan, researchers warn
11. Flatworm helps researchers study stem cells and cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... In the most densely forested and most densely populated ... of human needs, values and practices. Disturbances associated with ... agriculture and development, have set the stage for management ... study reports. , The report Five anthropogenic factors ... in the Northern United States was published ...
(Date:4/17/2014)... 2014The development of stem cell therapies to cure a ... stem cell populations based on cell surface markers. Researchers ... marker that is highly expressed in a type of ... they describe in an article in BioResearch Open ... Inc., publishers. The article is available free on the ...
(Date:4/17/2014)... detection cartridge developed at Sandia National Laboratories and recently ... faster and cheaper. , Bacillus anthracis , ... soils all over the world and can cause serious, ... The bacteria can survive in harsh conditions for decades. ... occur through skin contact, inhalation of spores or eating ...
Breaking Biology News(10 mins):Five anthropogenic factors that will radically alter northern forests in 50 years 2Five anthropogenic factors that will radically alter northern forests in 50 years 3Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3
... Wasps, bees, ants and relatives comprise the megadiverse ... speciose animal group on Earth, far surpassing the ... most diverse orders of animals (beetles, butterflies, wasps, ... insects with complete metamorphosis, i.e. having a dormant ...
... Elsevier, EuroStemCell, and Kyoto University,s Institute for Integrated ... Trends and Perspectives on the Evolving International Landscape" at ... of the growth and development of the stem cell ... for embryonic stem (ES) cell, human embryonic stem (hES) ...
... a scientist exposes rats to a certain pesticide over ... similar to those seen in Parkinson,s patients. But the ... affects 7 million to 10 million people worldwide, is ... Engineering News , the weekly newsmagazine of the American ...
Cached Biology News:Fossils clarify the origins of wasps and their kin: alderfly ancestors, snakefly cousins 2New report on stem cell research reveals the field is growing twice as fast as the world average 2New report on stem cell research reveals the field is growing twice as fast as the world average 3
(Date:1/14/2014)... WESTBOROUGH, Mass. , Jan. 14, 2014  RXi ... on discovering, developing and commercializing innovative therapies addressing ... announced that it received the Notice of Allowance ... on its unique self-delivering RNAi compounds (sd-rxRNA®), for ...
(Date:1/14/2014)... OTTAWA, Ontario , Jan. 14, 2014   Kinaxis ®, ... ( SCM ) and sales and operations planning ( S&OP ... the Biomanufacturing Summit , which will be held at ...  At the conference, join Kinaxis customer Elisabeth Kaszas , ...
(Date:1/14/2014)... Kerr Corporation, a leading manufacturer of innovative dental products, ... dual arch impressions on its dental blog. , ... entry serves up a list of tips to help dentists ... Dr. David Little as he crafts a porcelain crown using ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Independent publisher ... California, and Montreal, Canada, has big ideas for 2014 ... The press's goals are to produce high-quality, low-cost, DRM-free ... support local businesses. , The first major development ...
Breaking Biology Technology:RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2Bitingduck Press Looks Forward to 2014 With Multimedia E-books 2
... -- China,Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," ... in the People,s,Republic of China ("PRC"), today announced that ... on Tuesday, May 19, 2009, to discuss the 2009 ... the call will be Mr. Colin Zhao, Chief Executive ...
... the 92 naturally occurring elements, add another to the list ... professor of physics in Arts & Sciences at Washington University ... student at the time discovered that europium becomes superconducting ... of pressure, making it the 53rd known elemental superconductor and ...
... Nile Therapeutics, Inc. (Nasdaq: NLTX ), ... for heart failure patients, received notification from the U.S. ... released the Company,s CD-NP development program from clinical hold.As ... FDA the finalized protocol for the Company,s planned 30-patient ...
Cached Biology Technology:China Biologic Products Announces 2009 First Quarter Results Conference Call 2Europium discovery 2Europium discovery 3Nile Therapeutics CD-NP Clinical Program for Acute Heart Failure Released From Clinical Hold by FDA 2Nile Therapeutics CD-NP Clinical Program for Acute Heart Failure Released From Clinical Hold by FDA 3
...
... All MagCellect Ferrofluid products ... conjunction with R&D Systems MagCellect ... capacities, this neodymium iron boron ... 12 x 75 mm test ...
S. O'Hare & C.K. Atterwill • In vitro toxicity techniques for regular lab use. Ex vivo techniques are also covered with the aim of reducing and refining the use of animals in the future....
Agarase cleaves agarose to neoagaro-oligosaccharides, and is used for,quantitative, gentle recovery of DNA from low melting point agarose....
Biology Products: